FemTech Startups

Neiwai is a direct-to-consumer intimate apparel brand that manufactures seamless bras with adaptive fit technology designed for comfort and invisible wear under clothing.

1 investor

HerAnova develops non-invasive, blood-based diagnostics and treatments for endometriosis and infertility, aimed at improving women's health. It is building a suite of tests, including a blood-based test for detecting and confirming endometriosis.

1 investor

menopeer provides B2B research, consulting, marketing, and advertising services for companies targeting women in perimenopause and menopause, drawing on insights and a user base from its "Lumino" menopause app. Its clients include pharmaceutical, cosmetics/consumer-goods, OTC drug/food, advertising, retail, and service companies seeking to understand and reach this demographic.

1 investor

ninpath is a Japanese fertility treatment support service that lets patients record and manage their treatment history by cycle and compare their data against anonymized records of other users in similar situations. It also offers a career/job-matching service for women seeking flexible work arrangements (flextime, remote, shortened hours) compatible with ongoing fertility treatment, pregnancy, and child-rearing.

1 investor

TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.

1 investor

SUTELURA is a Japanese company that runs events and corporate health-management support focused on women's wellbeing and femtech, including International Women's Day events, healthcare seminars, and support for obtaining workplace certifications such as the Kurumin childcare-support mark. It serves women seeking more life choices and companies implementing health management and female-empowerment initiatives.

1 investor

3Daughters develops a frameless, non-hormonal intrauterine contraceptive device (IUD) designed to reduce insertion pain and improve the user experience for women. The company is preparing clinical trials for its magnetic IUD platform and exploring applications in targeted uterine drug delivery.

0 investors

Ceek Women's Health designs modern speculums and gynecological exam tools, including Nella, a reusable and single-use speculum line with integrated sidewall retractors intended to improve clinician efficiency and patient comfort. Its products are aimed at clinicians and women undergoing pelvic and cervical exams.

0 investors

Cerrx publishes online articles about menstrual and women's health topics, such as causes of blood clots during periods.

0 investors

CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.

0 investors

Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.

0 investors

Daré Bioscience is a female-led biotech company developing treatments for women's health conditions that are overlooked in the healthcare industry. The company uses rigorous clinical trial methods and evidence-based research to bring FDA-approved and pipeline therapeutics to patients through both traditional regulatory pathways and compounding services.

0 investors

Dilon Technologies is a medical device manufacturer that develops surgical instruments and diagnostic tools for healthcare practitioners, including gamma probes for lymphatic mapping, margin assessment devices for breast cancer surgery, and video laryngoscopes.

0 investors

Estrigenix Therapeutics is a pharmaceutical company developing first-in-class therapeutics based on estrogen biology to treat and prevent hot flashes and dementia in post-menopausal women. It aims to license its lead compounds to pharmaceutical companies after phase 2 clinical trials, offering menopause symptom relief without the breast cancer and stroke risks of traditional hormone replacement therapy.

0 investors

Femasys develops office-based medical devices for women's healthcare, including first-line fertility treatments (FemaSeed, FemHSG catheter) delivered by OB/GYNs and fertility specialists, and a minimally invasive permanent birth control system (FemBloc). Its products aim to provide more affordable, less invasive alternatives to IVF and surgical contraception.

0 investors

FemmePharma sells consumer health and personal care products (the Mia Vita line) addressing women's health needs across menstruation, motherhood, and menopause. The company also publishes educational content and maintains a community around women's health and wellness.

0 investors

Good Clean Love makes organic, body-safe intimate wellness and personal care products, including natural lubricants, sold direct to consumers and through retail. Founded in 2003, the brand focuses on certified organic ingredients and is distributed across the U.S.

0 investors

J3 Bio develops an FDA-cleared intravaginal ring platform called LivRing for delivering active and functional ingredients to address women's health needs across multiple conditions and life stages. The company targets the direct-to-consumer women's health market with clinically validated solutions designed for accessibility outside traditional medical channels.

0 investors

Luna Genetics is a clinical genetics company offering prenatal and pre-conception genetic testing and diagnosis, supported by genetic counseling services. It operates a clinical laboratory focused on reproductive and prenatal genetics.

0 investors

Mamaya Health is a digital mental health platform providing specialized counseling and care for women across their reproductive lifespan. The platform matches women with clinicians who understand their specific reproductive and menopausal needs, addressing gaps in accessible maternal and women's mental healthcare.

0 investors

Pediatrix (with Obstetrix) is a physician-led health care organization that partners with hospitals, health systems, and health care facilities to provide clinical specialist services. It develops care solutions serving hospitals, patients, referring physicians, and payors.

0 investors

Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.

0 investors

MetriTrack develops the FDA-cleared BVN model G-2000 (Breast Volume Navigator), an ultrasound system using dynamic mapping with anatomical referencing to locate and map breast lesions in women with dense breast tissue. The device targets supplemental breast cancer screening and care for a patient population underserved by mammography alone.

0 investors

NannoCare makes NannoPad, organic cotton sanitary pads that use its Nannogenic far-infrared technology to help relieve menstrual cramps and discomfort. The direct-to-consumer products target women seeking natural period care and menstrual pain relief.

0 investors